Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1973 1
1974 1
1975 1
1976 1
1983 1
1985 2
1988 3
1989 2
1990 2
1991 3
1993 1
1996 3
1997 4
1998 2
1999 2
2000 1
2001 1
2003 6
2004 1
2005 1
2006 6
2007 8
2008 3
2009 6
2010 8
2011 11
2012 9
2013 10
2014 13
2015 13
2016 16
2017 12
2018 8
2019 12
2020 28
2021 35
2022 26
2023 25
2024 25
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Results by year

Filters applied: . Clear all
Page 1
Takotsubo cardiomyopathy.
Matta A, Delmas C, Campelo-Parada F, Lhermusier T, Bouisset F, Elbaz M, Nader V, Blanco S, Roncalli J, Carrié D. Matta A, et al. Rev Cardiovasc Med. 2022 Jan 20;23(1):38. doi: 10.31083/j.rcm2301038. Rev Cardiovasc Med. 2022. PMID: 35092230 Free article. Review.
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M, Kanekiyo M, Li D, Purcell D, Dhadda S, Irizarry M, Kramer L. Honig LS, et al. Among authors: matta a. Alzheimers Res Ther. 2024 May 10;16(1):105. doi: 10.1186/s13195-024-01441-8. Alzheimers Res Ther. 2024. PMID: 38730496 Free PMC article. Clinical Trial.
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.
Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A, Turner T, Wallström E, Zhang X, Mareš M, Khabirov FA, Traboulsee A; Tolebrutinib Phase 2b Study Group. Reich DS, et al. Among authors: matta a. Lancet Neurol. 2021 Sep;20(9):729-738. doi: 10.1016/S1474-4422(21)00237-4. Lancet Neurol. 2021. PMID: 34418400 Free PMC article. Clinical Trial.
Coronary artery aneurysm: A review.
Matta AG, Yaacoub N, Nader V, Moussallem N, Carrie D, Roncalli J. Matta AG, et al. World J Cardiol. 2021 Sep 26;13(9):446-455. doi: 10.4330/wjc.v13.i9.446. World J Cardiol. 2021. PMID: 34621489 Free PMC article. Review.
Retraction.
Pasek RC, Dunn JC, Elsakr JM, Aramandla M, Matta AR, Gannon M. Pasek RC, et al. Among authors: matta ar. Am J Physiol Endocrinol Metab. 2017 Jul 1;313(1):E105. doi: 10.1152/ajpendo.zh1-7764-retr.2017. Am J Physiol Endocrinol Metab. 2017. PMID: 28687703 Free PMC article. No abstract available.
Role of Bronchoscopy in Diagnosis of Sarcoidosis.
Benzaquen S, Matta A, Sultan S, Sarvottam K. Benzaquen S, et al. Among authors: matta a. Clin Chest Med. 2024 Mar;45(1):25-32. doi: 10.1016/j.ccm.2023.08.001. Epub 2023 Dec 18. Clin Chest Med. 2024. PMID: 38245368 Review.
Post-mRNA COVID-19 Vaccination Myocarditis.
Matta A, Kallamadi R, Matta D, Bande D. Matta A, et al. Eur J Case Rep Intern Med. 2021 Aug 16;8(8):002769. doi: 10.12890/2021_002769. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 34527626 Free PMC article.
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M, Kanekiyo M, Li D, Purcell D, Dhadda S, Irizarry M, Kramer L. Honig LS, et al. Among authors: matta a. Alzheimers Res Ther. 2024 Jul 10;16(1):159. doi: 10.1186/s13195-024-01507-7. Alzheimers Res Ther. 2024. PMID: 38987826 Free PMC article. No abstract available.
293 results